Weight-loss drugs: Can Ozempic and other drugs change the landscape of India's wellness industry?
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...
pharmaphorum1d
Astellas hit by US patent verdict for incontinence drug
Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...
Indiatimes1d
Cadila Healthcare - Zydus Lifesciences Share Price
Zydus Lifesciences Ltd. key Products/Revenue Segments include ... As on 30-09-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 1004.40. On ...
pharmaphorum2d
Long-acting injectables for biologics: Current landscape and future perspective
He has worked with Zydus Cadila, Cadila Pharma, Panacea Biotech, and Ipca Labs in different capacities. Dr Pratima Srivastava is VP of DMPK at Aragen Life Sciences. She has more than two decades ...